- Country: Brazil
- Summary: Medicine Acquisition
- BRT Ref No: 70680315
- Deadline: 01 Sep 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 136/2021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase of medicine
Expected execution deadline: 365 Days
Session opening: 01/09/2022 Time: 1000 AM
Composition of items:
Sequence - Summary Description - Unit of Measurement - Quantity
1 - LOPERAMIDE Hydrochloride 2mg - capsule/tablet - 1298534
2 - Dimenhydrinate 50mg+ pyridoxy - capsule/tablet - 81300
3 - where you think is 8mg Hydrochloride - Capsule/Compressed - 950270
4 - Mebeverin Hydrochloride - Capsule/Compressed - 434946
5 - Sodico rabeprazol - capsule/tablet - 51384
6 - Meclozine - Capsule/Compressed - 42706
7 - SAPROPTERINE - Dispersible tablet - 695460
8 - Glycerol 2.47g - Suppositorio - 59318
9 - Dexlansoprazole 60 - Capsule/tablet - 39860
10 - Pantoprazol 20 - Capsule/Compressed - 217962 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicine Acquisition - Brazil Tender
The PHARMACEUTICAL ASSISTANCE COORDINATION, a Government sector organization in Brazil, has announced a new tender for Medicine Acquisition. This tender is published on BrazilTenders under BRT Ref No: 70680315 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-09-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
